Topic: drug shortage

Teva will begin producing chemo drug vincristine in the U.S. but has resisted the idea that its withdrawal from the market led to a shortage.

A new FDA report offers up suggestions new and old on how to reduce the number of drugs shortages faced by consumers and providers.

Pfizer's role as the hero in ramping up production of a chemo drug badly needed by pediatric oncologists is a turnabout for the drugmaker.

With hundreds of drug shortages hitting the pharmaceutical industry each quarter, Merck KGaA is hoping a novel machine-learning platform will help.

Swine fever in China has forced one of the largest manufacturers of heparin to begin limiting allocations of the treatment.

Takeda says supplies of primary immune deficiency treatment Gammagard Liquid will remain spotty this year as it ramps up production at a new plant.

B. Braun Medical will invest $1 billion to build a new plant in Florida and expand two other facilities to help address U.S. IV fluid shortages.

After supply constraints hindered Shingrix's launch last year, GSK is planning to expand adjuvant manufacturing operations in Montana.

The FDA is allowing some drugmakers to exceed the level of risk from a probable cancer-causing impurity in losartan for six months.

C2 Pharma’s deal for the digoxin portfolio of Poland's Nobilus will give it two supplies of API for making the sometimes-difficult-to-get drug.